Filing Details
- Accession Number:
- 0000899243-15-009193
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-02 19:41:10
- Reporting Period:
- 2015-12-01
- Filing Date:
- 2015-12-02
- Accepted Time:
- 2015-12-02 19:41:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1478121 | Pfenex Inc. | PFNX | Pharmaceutical Preparations (2834) | 271356759 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612846 | Jr. W. Henry Talbot | Co Pfenex Inc, 10790 Roselle Street San Diego CA 92121 | Vp Of Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-12-01 | 2,000 | $15.08 | 118,678 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the weighted average share price of an aggregate total of 2,000 shares sold in the price range of $15.00 to $15.56 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer of security holder of the issuer, full information regarding the number of shares sold at separate price.
- Includes 688 shares acquired under the PFNX employee stock purchase plan on February 17, 2015 and 700 shares acquired under the PFNX employee stock purchase plan on August 17, 2015.
Billionaire Hedge Funds
